Trial · NCT01328379
Results by group21
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 21
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Walking Speed Near Maximum Plasma Concentration at Steady State (CmaxSS) of Placebo and Dalfampridine-ER (5mg and 10mg), Using the Timed 25 Foot Walk (T25FW). | Placebo | 0.363 | Standard Error 0.0511 | feet per second | |
| Change From Baseline in Walking Speed Near Maximum Plasma Concentration at Steady State (CmaxSS) of Placebo and Dalfampridine-ER (5mg and 10mg), Using the Timed 25 Foot Walk (T25FW). | Dalfampridine-ER 5mg | 0.423 | Standard Error 0.0470 | feet per second | |
| Change From Baseline in Walking Speed Near Maximum Plasma Concentration at Steady State (CmaxSS) of Placebo and Dalfampridine-ER (5mg and 10mg), Using the Timed 25 Foot Walk (T25FW). | Dalfampridine-ER 10mg | 0.478 | Standard Error 0.0569 | feet per second | |
| Change From Baseline in Walking Speed Near Minimum Plasma Concentration at Steady State (CminSS) of Placebo, Dalfampridine-ER (5mg and 10mg), Using the Timed 25 Foot Walk (T25FW). | Placebo | 0.301 | Standard Error 0.0496 | feet per second | |
| Change From Baseline in Walking Speed Near Minimum Plasma Concentration at Steady State (CminSS) of Placebo, Dalfampridine-ER (5mg and 10mg), Using the Timed 25 Foot Walk (T25FW). | Dalfampridine-ER 5mg | 0.296 | Standard Error 0.0429 | feet per second | |
| Change From Baseline in Walking Speed Near Minimum Plasma Concentration at Steady State (CminSS) of Placebo, Dalfampridine-ER (5mg and 10mg), Using the Timed 25 Foot Walk (T25FW). | Dalfampridine-ER 10mg | 0.391 | Standard Error 0.0513 | feet per second | |
| Change From Baseline in 12-item MS Walking Scale (MSWS-12) at Visit 3 | Placebo | -8.35 | Standard Error 1.774 | scores on a scale | |
| Change From Baseline in 12-item MS Walking Scale (MSWS-12) at Visit 3 | Dalfampridine-ER 5mg | -9.73 | Standard Error 1.741 | scores on a scale | |
| Change From Baseline in 12-item MS Walking Scale (MSWS-12) at Visit 3 | Dalfampridine-ER 10mg | -11.10 | Standard Error 1.818 | scores on a scale | |
| Change From Baseline in MSWS-12 at Visit 2 | Placebo | -9.48 | Standard Error 1.713 | scores on a scale | |
| Change From Baseline in MSWS-12 at Visit 2 | Dalfampridine-ER 5mg | -9.54 | Standard Error 1.526 | scores on a scale | |
| Change From Baseline in MSWS-12 at Visit 2 | Dalfampridine-ER 10mg | -10.04 | Standard Error 1.817 | scores on a scale | |
| Change From Baseline in Six-Minute Walk Distance at Visit 2 | Placebo | 41.7 | Standard Error 23.36 | Feet | |
| Change From Baseline in Six-Minute Walk Distance at Visit 2 | Dalfampridine-ER 5mg | 76.8 | Standard Error 27.31 | Feet | |
| Change From Baseline in Six-Minute Walk Distance at Visit 2 | Dalfampridine-ER 10mg | 128.6 | Standard Error 21.66 | Feet | |
| Change From Baseline in EuroQol Group 5 Dimensions (EQ-5D) Scores at Visit 3. | Placebo | -0.07 | Standard Error 0.023 | units on a scale | |
| Change From Baseline in EuroQol Group 5 Dimensions (EQ-5D) Scores at Visit 3. | Dalfampridine-ER 5mg | -0.05 | Standard Error 0.020 | units on a scale | |
| Change From Baseline in EuroQol Group 5 Dimensions (EQ-5D) Scores at Visit 3. | Dalfampridine-ER 10mg | -0.07 | Standard Error 0.024 | units on a scale | |
| Change From Baseline in EQ-5D Visual Analogue Self-rating (VAS) Score at Visit 3. | Placebo | 7.0 | Standard Error 1.43 | units on a scale | |
| Change From Baseline in EQ-5D Visual Analogue Self-rating (VAS) Score at Visit 3. | Dalfampridine-ER 5mg | 2.6 | Standard Error 1.53 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01328379/results